An interventional study of Nicotine patch and lozenges and Telephone counseling sessions in Smoking, Tobacco Use and Lung Cancer, sponsored by H. Lee Moffitt Cancer Center and Research Institute. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-06.
Sponsored by H. Lee Moffitt Cancer Center and Research Institute · Not applicable, Interventional, and Prevention
The purpose of the study is to pilot test a multi-modal smoking cessation and relapse prevention intervention with the lung cancer patient population and to obtain preliminary data on its feasibility.
268 studies on the registry are indexed under Smoking; 136 are open to participants now.
This study's enrollment of 21 is below the median of 120 across 211 interventional studies indexed under Smoking.
Browse Smoking studies →H. Lee Moffitt Cancer Center and Research Institute is the lead sponsor of 533 studies on the registry; 74 are open to participants now.
Of its 99 completed or terminated interventional studies of FDA-regulated products, 57 (58%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Participants will receive brief advice to quit, an offer of enrollment to the Florida Tobacco Quitline, and a 12 week supply of nicotine replacement therapy (nicotine patches and lozenges).
Drug: Nicotine patch and lozenges · Behavioral: Florida Tobacco Quitline
Participants will receive brief advice to quit, an offer of enrollment to the Florida Tobacco Quitline, and a 12 week supply of nicotine replacement therapy (nicotine patches and lozenges), 6 telephone counseling sessions over 6 months, and access to a web based video.
Drug: Nicotine patch and lozenges · Behavioral: Telephone counseling sessions · Behavioral: Access to a web-based video · Behavioral: Florida Tobacco Quitline
Participants will receive nicotine patch and lozenges. The regimen will be based on the participant's self-reported smoking rate. At the time of enrollment, a research staff member will determine the proper dose. Participants who smoke \>10 cigarettes/day will receive 8 weeks of 21 mg. patches, 2 weeks of 14 mg. patches, 2 weeks of 7 mg. patches, and 12 weeks of 2 mg. lozenges. Those who smoke \<10 cigarettes/day will receive 8 weeks of 14 mg. patches, 4 weeks of 7 mg patches, and 12 weeks of 2 mg. lozenges
Participants will be offered 6 Motivation and Problem Solving (MAPS)-based counseling sessions by phone over a 6-month period.
Participants will be given web-based access to the relapse prevention video "Surviving Smokefree".
Participants will receive an offer of enrollment to the Florida Tobacco Quitline which enables participant to speak with a Quit Coach who will assess nicotine addiction and help create a quit plan.
Percentage of Participants who meet inclusion criteria
Percentage of participants who meet inclusion criteria
Time frame: Baseline
Percentage of participants who agree to participate in the study
Percentage of participants who agree to participate in the study
Time frame: Baseline
Percentage of participants completing baseline assessment
Percentage of participants completing baseline assessment
Time frame: Baseline
Percentage of participants completing the 3 month follow-up assessments
Percentage of participants completing the 3 month follow-up assessments
Time frame: at 3 months
Percentage of participants completing the 6 month follow-up assessments
Percentage of participants completing the 6 month follow-up assessments
Time frame: at 6 months
Treatment satisfaction - Acceptability
Mean scores of the Client Satisfaction Questionnaire (SCQ-8) will be used for this measure. The CSQ-8 comprises 8 items for the assessment of treatment satisfaction using a scale from 8 to 32, with higher scores indicating greater satisfaction.
Time frame: at 6 months
Completion rate of MAPS calls for UC+MAPS+RP participants - Demand
Percentage of MAPS calls completed for UC+MAPS+RP participants
Time frame: at 6 months
Percentage of UC+MAPS+RP participants who viewed the web-based video -Demand
Percentage of UC+MAPS+RP participants who viewed the web based video
Time frame: at 3 months
Percentage of UC+MAPS+RP participants who viewed the web-based video -Demand
Percentage of UC+MAPS+RP participants who viewed the web based video
Time frame: at 6 months
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
H. Lee Moffitt Cancer Center and Research Institute